WallStreetZenWallStreetZen

NYSE: ADCT
Adc Therapeutics Sa Stock Ownership - Who owns Adc Therapeutics Sa?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Adc Therapeutics Sa insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robert AzelbyDirector2025-06-1312,600$3.58
$45.11kSell
Jeanpierre BizzariDirector2025-06-1312,600$3.58
$45.11kSell
Peter HugDirector2025-06-132,144$3.58
$7.68kSell
Viviane MongesDirector2025-06-132,584$3.58
$9.25kSell
Victor SandorDirector2025-06-1312,600$3.58
$45.11kSell
Ron SquarerDirector2025-06-1315,184$3.58
$54.36kSell
Ameet MallikChief Executive Officer2025-05-0626,758$1.29
$34.52kSell
Mohamed ZakiChief Medical Officer2025-02-13230,000$1.61
$370.30kBuy
Peter J. GrahamChief Legal Officer2025-02-13220,000$1.61
$354.20kBuy
Jose CarmonaChief Financial Officer2025-02-13240,000$1.61
$386.40kBuy

1 of 3

ADCT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADCT insiders and whales buy or sell their stock.

ADCT Shareholders

What type of owners hold Adc Therapeutics Sa stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Redmile Group LLC25.61%28,812,443$128.50MInsider
Redmile Group LLC13.93%15,666,731$69.87MInstitution
Prosight Management LP9.30%10,467,771$46.69MInstitution
Hans Peter Wild8.70%9,788,944$43.66MInsider
Point72 Asset Management LP6.90%7,763,658$34.63MInstitution
Orbimed Advisors LLC5.25%5,907,351$26.35MInstitution
Blackrock Inc4.02%4,521,343$20.17MInstitution
Morgan Stanley2.71%3,045,573$13.58MInstitution
Heights Capital Management Inc2.52%2,832,861$12.63MInstitution
Nantahala Capital Management LLC2.01%2,266,289$10.11MInstitution

1 of 3

ADCT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADCT60.40%38.28%Net Buying
LXRX21.70%78.30%Net Selling
RAPT30.45%69.55%
OMER42.72%5.30%
DBVT4.28%21.82%Net Selling
View Top Biotech Stocks

Adc Therapeutics Sa Stock Ownership FAQ

Who owns Adc Therapeutics Sa?

Adc Therapeutics Sa (NYSE: ADCT) is owned by 60.40% institutional shareholders, 38.28% Adc Therapeutics Sa insiders, and 1.32% retail investors. Redmile Group LLC is the largest individual Adc Therapeutics Sa shareholder, owning 28.81M shares representing 25.61% of the company. Redmile Group LLC's Adc Therapeutics Sa shares are currently valued at $128.50M.

If you're new to stock investing, here's how to buy Adc Therapeutics Sa stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.